However, tumor tissue exhibited higher levels of immune checkpoint-related ligand-receptors, such as LGALS9-HAVCR2, LAGALS9-CD44, ICOSL-ICOS, ICOSL-CTLA4, and ICOSL-CD28. The gene discussed is CTLA4; the disease is neoplasm.